Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Extended-release oxycodone	Oxycodone	[3] D03783, D05312, D05462 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 13 💬
2	Oxycodone	Oxycodone	[3] D03783, D05312, D05462 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[7]  6 , 13, 46, 70, 226, 231, 298 💬
3	Oxycodone by patient-controlled analgesia (pca)	Oxycodone	[3] D03783, D05312, D05462 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 46 💬
4	Oxycodone depot ”sandoz”, depot tablets	Oxycodone	[3] D03783, D05312, D05462 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 298 💬
5	Oxycodone hydrochloride	Oxycodone	[3] D03783, D05312, D05462 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[4]  6 , 70, 226, 298 💬
6	Oxycodone naloxone prolonged release tablets	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
7	Oxycodone orion	Oxycodone	[3] D03783, D05312, D05462 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 70 💬
8	Oxycodone/acetaminophen	Acetaminophen	[4] D00217, D03783, D05312, D05462 💬	[5] OPRD1, OPRK1, OPRM1, PTGS1, PTGS2 💬	[28] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Estrogen signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Sphingolipid signaling pathway, TNF signaling pathway, VEGF signaling pathway, cGMP-PKG signaling pathway	[1] 231 💬
9	Oxycodone/naloxone prolonged release t	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
10	Oxycodone/naloxone prolonged release tablets	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
11	Oxycodone/naloxone prolonged release tablets 10 mg /5 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
12	Oxycodone/naloxone prolonged release tablets 10/5 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
13	Oxycodone/naloxone prolonged release tablets 20 mg /10 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
14	Oxycodone/naloxone prolonged release tablets 20/10 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
15	Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬
16	Oxycodone/naloxone prolonged release tablets 5/2.5 mg	Naloxone	[5] D01340, D03783, D05312, D05462, D08249 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1] 226 💬
17	Pr oxycodone	Oxycodone	[3] D03783, D05312, D05462 💬	[3] OPRD1, OPRK1, OPRM1 💬	[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway	[1]  6  💬